Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.62 HKD | -0.71% |
|
-.--% | -.--% |
14/06 | Venus Medtech Venusp-Valve Completes First Implantation in Ide Pivotal Clinical Study in U.S | CI |
14/06 | Venus Medtech (Hangzhou) Implants First Patient with VenusP-Valve in US Clinical Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-.--% | 31Cr | |
+10.87% | 13TCr | |
-8.56% | 1.08TCr | |
-21.01% | 705.55Cr | |
+50.07% | 649.55Cr | |
-34.16% | 398.87Cr | |
+8.50% | 344.12Cr | |
-20.67% | 245.24Cr | |
-19.70% | 188.51Cr | |
-22.48% | 175.16Cr |
- Stock Market
- Equities
- 2500 Stock
- News Venus Medtech (Hangzhou) Inc.
- Venus Medtech Completes First-in-Human Study of Bioprosthetic Heart Valve Product